RWA Wealth Partners’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $724K | Sell |
4,289
-541
| -11% | -$92.5K | 0.01% | 390 |
|
|
2025
Q4 | $815K | Sell |
4,830
-13
| -0.3% | -$2.11K | 0.01% | 368 |
|
|
2025
Q3 | $699K | Sell |
4,843
-886
| -15% | -$121K | 0.01% | 391 |
|
|
2025
Q2 | $725K | Sell |
5,729
-2,773
| -33% | -$340K | 0.01% | 373 |
|
|
2025
Q1 | $1.09M | Sell |
8,502
-2,787
| -25% | -$378K | 0.01% | 311 |
|
|
2024
Q4 | $1.49M | Sell |
11,289
-745
| -6% | -$105K | 0.02% | 276 |
|
|
2024
Q3 | $1.75M | Sell |
12,034
-829
| -6% | -$120K | 0.02% | 261 |
|
|
2024
Q2 | $1.77M | Sell |
12,863
-864
| -6% | -$115K | 0.02% | 249 |
|
|
2024
Q1 | $1.88M | Sell |
13,727
-5
| -0% | -$683 | 0.03% | 247 |
|
|
2023
Q4 | $1.87M | Sell |
13,732
-560
| -4% | -$68.3K | 0.03% | 236 |
|
|
2023
Q3 | $1.75M | Sell |
14,292
-3,092
| -18% | -$393K | 0.04% | 145 |
|
|
2023
Q2 | $2.21M | Sell |
17,384
-1,273
| -7% | -$165K | 0.05% | 125 |
|
|
2023
Q1 | $2.41M | Sell |
18,657
-785
| -4% | -$103K | 0.06% | 92 |
|
|
2022
Q4 | $2.61M | Sell |
19,442
-21,348
| -52% | -$2.76M | 0.06% | 94 |
|
|
2022
Q3 | $4.77M | Sell |
40,790
-952
| -2% | -$118K | 0.34% | 67 |
|
|
2022
Q2 | $4.91M | Buy |
41,742
+16,630
| +66% | +$1.97M | 0.33% | 64 |
|
|
2022
Q1 | $3.27M | Buy |
25,112
+37
| +0.1% | +$4.82K | 0.21% | 87 |
|
|
2021
Q4 | $3.83M | Buy |
25,075
+8,962
| +56% | +$1.39M | 0.26% | 81 |
|
|
2021
Q3 | $2.6M | Sell |
16,113
-6
| -0% | -$1.01K | 0.19% | 91 |
|
|
2021
Q2 | $2.64M | Buy |
16,119
+440
| +3% | +$67.8K | 0.2% | 86 |
|
|
2021
Q1 | $2.36M | Sell |
15,679
-37,418
| -70% | -$5.94M | 0.19% | 91 |
|
|
2020
Q4 | $8.04M | Buy |
53,097
+33,668
| +173% | +$4.81M | 0.71% | 30 |
|
|
2020
Q3 | $2.63M | Sell |
19,429
-45,316
| -70% | -$6.15M | 0.28% | 74 |
|
|
2020
Q2 | $8.85M | Buy |
64,745
+44,945
| +227% | +$5.73M | 1.08% | 20 |
|
|
2020
Q1 | $2.13M | Sell |
19,800
-796
| -4% | -$91.6K | 0.3% | 65 |
|
|
2019
Q4 | $2.48M | Buy |
20,596
+357
| +2% | +$39.8K | 0.25% | 80 |
|
|
2019
Q3 | $2.01M | Sell |
20,239
-304
| -1% | -$31.8K | 0.21% | 92 |
|
|
2019
Q2 | $2.24M | Buy |
20,543
+525
| +3% | +$55.8K | 0.24% | 86 |
|
|
2019
Q1 | $2.24M | Sell |
20,018
-243
| -1% | -$26.7K | 0.26% | 88 |
|
|
2018
Q4 | $1.95M | Buy |
20,261
+779
| +4% | +$82.7K | 0.26% | 85 |
|
|
2018
Q3 | $2.38M | Buy |
19,482
+3,500
| +22% | +$412K | 0.27% | 86 |
|
|
2018
Q2 | $1.75M | Buy |
15,982
+421
| +3% | +$45K | 0.2% | 104 |
|
|
2018
Q1 | $1.66M | Buy |
15,561
+1,432
| +10% | +$159K | 0.21% | 88 |
|
|
2017
Q4 | $1.51M | Sell |
14,129
-48,202
| -77% | -$5.15M | 0.17% | 102 |
|
|
2017
Q3 | $6.93M | Buy |
+62,331
| New | +$6.66M | 0.78% | 30 |
|
Other funds holding IBB
CB
RWA Wealth Partners's IBB Position: Q1 2026 in Review
RWA Wealth Partners reduced its iShares Biotechnology ETF (IBB) stake by 11% in Q1 2026, selling an estimated $92.5K and leaving 4,289 shares worth $724K. The position accounts for 0.01% of the portfolio, ranked #390.
RWA Wealth Partners first reported a position in IBB in Q3 2017 and has held it in 35 quarters since. The position peaked at $8.85M in Q2 2020. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.
- RWA Wealth Partners held 4,289 shares of iShares Biotechnology ETF worth $724K as of Q1 2026.
- RWA Wealth Partners sold 541 iShares Biotechnology ETF shares in Q1 2026, an estimated $92.5K.
- iShares Biotechnology ETF made up 0.01% of RWA Wealth Partners's portfolio in Q1 2026, its #390 holding.
- RWA Wealth Partners first reported a position in iShares Biotechnology ETF in Q3 2017 and has held it in 35 quarters since.
- RWA Wealth Partners's iShares Biotechnology ETF position peaked at $8.85M in Q2 2020.
- 917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.
Based on RWA Wealth Partners's 13F filing for Q1 2026, filed 13 May 2026.